Novartis News

European shares declined as rising oil prices, fueled by Middle East tensions, intensified inflation concerns, while Novartis plunged due to a drug trial setbac

European shares were subdued due to surging crude oil prices and US-Iran tensions, which heightened inflation concerns and led investors to anticipate further E

European shares were subdued on Monday due to rising oil prices, fueled by US-Iran tensions, which renewed inflation fears. Investors are awaiting the European

The heart drug Pelacarsen, developed by Novartis, failed in a large clinical trial, surprising both the company and cardiologists who had hoped it would be a si

The Delhi High Court is examining Natco Pharma's petition challenging a breast cancer drug patent held by Novartis and Astex. Natco claims the two companies sec

Natco has challenged Novartis's second patent for the cancer drug ribociclib in the Delhi High Court, alleging it unlawfully extends Novartis's market monopoly